Chimerix's Total Assets for the quarter that ended in Dec. 2024 was $146.01 Mil.
During the past 12 months, Chimerix's average Total Assets Growth Rate was -52.00% per year.
During the past 3 years, the average Total Assets Growth Rate was 5.70% per year.
During the past 5 years, the average Total Assets Growth Rate was 37.00% per year.
During the past 10 years, the average Total Assets Growth Rate was -13.60% per year.
During the past 13 years, Chimerix's highest 3-Year average Total Assets Growth Rate was 290.60%. The lowest was -68.60%. And the median was 42.80%.
Total Assets is connected with ROA %. Chimerix's annualizedROA % for the quarter that ended in Dec. 2024 was -60.27%. Total Assets is also linked to Revenue through Asset Turnover. Chimerix's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.
Chimerix Total Assets Historical Data
The historical data trend for Chimerix's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Chimerix's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Net Income data used here is four times the quarterly (Dec. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Chimerix's Asset Turnover for the quarter that ended in Dec. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Chimerix Total Assets Related Terms
Thank you for viewing the detailed overview of Chimerix's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CMRX has been successfully added to your 